MentalHealthDaily

ED Naloxone Need: 3.87M At-Risk Visits vs. 226K Overdoses

by GLOOM

MHD featured image for emergency department naloxone distribution and opioid overdose prevention.

A 2026 emergency department claims analysis estimated 3.87 million United States ED visits in 2021 where take-home naloxone could have been clinically relevant, compared with 226,453 ED-treated opioid-overdose visits in the same database.1 The finding reframes naloxone distribution as an emergency-care workflow for overdose risk, polysubstance exposure, long-term opioid use, and patients who arrive after …

Levetiracetam After Stroke: 9 Fewer Deaths in Older Adults

by GLOOM

MHD featured image for levetiracetam continuation, post-stroke seizure prevention, and 90-day survival in older adults.

A 2026 Medicare target-trial emulation found continued levetiracetam after acute ischemic stroke was associated with 53 vs. 62 deaths per 1,000 over 90 days, a risk difference of −9 deaths per 1,000 favoring continuation. Research Highlights Survival signal: continued levetiracetam after an initial month of post-stroke use was linked to 53 deaths per 1,000 vs. …